Studies have demonstrated the role of neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1) and periostin in the earlier diagnosis of DN, and while still mostly available in research settings, these biomarkers show growing translational potential [6]. The gene discussed is HAVCR1; the disease is liver dysplastic nodule.